Medicare finalizes policy limiting coverage of Biogen Alzheimer's drug
Bio Pharma Dive
APRIL 7, 2022
Treatment with Aduhelm would only be covered for patients enrolled in a clinical trial under the policy, which largely follows a draft proposal released in January.
Let's personalize your content